Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 554 results for "clinigene"

Clinigen set to lead unlicensed drugs market

The Financial Times Ltd 2015 FT and 'Financial Times' are trademarks of The Financial Times Ltd. SHARE THIS QUOTE Tweet this quote Printed from: http://www.ft.com/cms/s/0/c7fa0d9a-ead8-11e4-96ec-00144feab7de.html Print a single copy of this article ... Austin American Statesman, 11 hours ago

18 images for clinigene

SleekMoney, 5 days ago
SleekMoney, 1 month ago
Mideast Time, 1 month ago
Proactive Investors.co.uk, 1 month ago
DirectorsTalk, 1 month ago
Proactive Investors.co.uk, 1 month ago
Proactive Investors.co.uk, 1 month ago
Proactive Investors.co.uk, 1 month ago
Investing.com, 1 month ago
Proactive Investors.co.uk, 1 month ago

Clinigen Group plc to acquire Idis Group Holdings Ltd

Thomson Reuters is the world's largest international multimedia news agency, providing investing news , world news , business news , technology news , headline news, small business news , news alerts, personal finance , stock market , and mutual ...
 Reuters2 days ago Clinigen Group Plc sees FY 2015 outlook to meet Board's expectations  Reuters1 month ago

Why Shares In Clinigen Group PLC Jumped More Than 10% Today

Clinigen (LSE: CLIN), the speciality pharmaceutical company, surged more than 10% in early trade today after the company announced that it has agreed to acquire Idis Group Holdings Limited. The deal will create a market leader in the market for the ...
 Yahoo! UK and Ireland2 days ago

BRIEF-Clinigen Group agrees to buy Idis for 225 million pounds

April 24 (Reuters) - Clinigen Group Plc * £225 million acquisition of idis and £135 million vendor placing Source text for Eikon: Further
 Reuters UK2 days ago
Proactive Investors.co.uk

Clinigen extends Foscavir US...

Clinigen Group Clinigen Group has extended the exclusive licensing and distribution agreement for the anti-viral product Foscavir (foscarnet sodium) in the US with Hospira. The original distribution agreement with Hospira established in July 2011 ...
 This is Money1 month ago Clinigen extends Foscavir US dist...  TrustNet1 month ago Clinigen Group Extends Exclusive Foscavir US Distribution Agreement with Hospira to 2019  PharmaAsia1 month ago CLINIGEN : Extends Foscavir US Distribution Contract  4 Traders1 month ago
[x]  

Clinigen Group Posts Half Year Financial Results

Clinigen Group published its half year results for the six months ended 31 December 2014. In its release on March 3, the Company noted report details: Financial highlights -Group revenue up 17 percent to GBP72.6m (H1FY14: GBP61.8m); on a ...
 Individual.com1 month ago Clinigen CEO reveals more deals to come in next month or so  Proactive Investors.co.uk1 month ago Clinigen schedules interims  Interactive Investor2 months ago

MARKET REPORT: Clinigen scores for Aston Villa nut Andrew Derrick Leaver as shares rocket after 'transformational' deal

The page you requested could not found. Please use the top or bottom navigation. MoneyAM.com MoneyAM website is aimed at investors of all levels of experience including City professionals, investors and full-time traders. Free live share ...
 Stock Market Wire2 days ago

Numis stays buy on Clinigen, target raised to 860p from 770p

Story provided by StockMarketWire.com 2015 MoneyAM Register now for FREE Share Prices, Stock Quotes, Charts, Bulletin Boards, Indices, Watchlists, Portfolio, Market News, Research or see our Premium Services including Level 2, Terminal and
 MoneyAM2 days ago CLINIGEN : *numis raises clinigen price target to 860 (770) pence - 'buy'  4 Traders2 days ago FLASH: Numis stays buy on Clinigen,...  This is Money2 days ago Numis reiterates buy on Clinigen Group, target raised from 650p to 770p  MoneyAM1 month ago
[x]  
Investing.com

Clinigen (#CLIN) announces £225m purchase of IDIS and a £135m vendorplacing

 Share Prophets2 days ago Clinigen Group plc £225M Acquisition of Idis; £135m Vendor Placing  ADVFN UK2 days ago CLINIGEN : £225M Acquisition of Idis; £135m Vendor Placing  4 Traders2 days ago Clinigen : £225 million Acquisition of Idis and £135 million Vendor Placing  4 Traders2 days ago
[x]  

Clinigen now global leader in unlicensed medicines after Idis deal

The Clinigen Group is a specialty global pharmaceutical company headquartered in the UK, with offices in the US and Japan. The Group, dedicated to delivering the right drug, to the right patient at the right time, has three operating businesses; ...
 Proactive Investors.co.uk2 days ago Clinigen moves into unlicensed drugs supply with Idis deal  London South East2 days ago REUTERS - Clinigen moves into unlicensed drugs supply with Idis deal  Namibia Press Agency2 days ago Clinigen eyes 'world-leading' position as sales rise  Insider Media Limited1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less